These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24752447)

  • 1. Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules.
    Allard M; Oger R; Benlalam H; Florenceau L; Echasserieau K; Bernardeau K; Labarrière N; Lang F; Gervois N
    J Immunol; 2014 Jun; 192(11):5090-7. PubMed ID: 24752447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.
    Poggi A; Contini P; Catellani S; Setti M; Murdaca G; Zocchi MR
    Eur J Immunol; 2005 Sep; 35(9):2670-8. PubMed ID: 16114098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
    Zandvliet ML; Kester MG; van Liempt E; de Ru AH; van Veelen PA; Griffioen M; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2012; 35(2):142-53. PubMed ID: 22306902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes.
    Puppo F; Contini P; Ghio M; Brenci S; Scudeletti M; Filaci G; Ferrone S; Indiveri F
    Int Immunol; 2000 Feb; 12(2):195-203. PubMed ID: 10653855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
    Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
    Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse.
    Zhong M; Weng X; Liang Z; Lu S; Li J; Chen X; Li Q; Sun W; Song Y; Shen G; Wu X
    Transplantation; 2009 Jan; 87(1):8-15. PubMed ID: 19136885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
    Joosten SA; van Meijgaarden KE; van Weeren PC; Kazi F; Geluk A; Savage ND; Drijfhout JW; Flower DR; Hanekom WA; Klein MR; Ottenhoff TH
    PLoS Pathog; 2010 Feb; 6(2):e1000782. PubMed ID: 20195504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble plasma HLA peptidome as a potential source for cancer biomarkers.
    Bassani-Sternberg M; Barnea E; Beer I; Avivi I; Katz T; Admon A
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18769-76. PubMed ID: 20974924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro refolding and functional study of soluble HLA-G1-peptide complex].
    Yang JN; Wu XW; Liang ZH; Han JY; Huang YF; Gong FL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):265-8. PubMed ID: 15862135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
    Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
    Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an HLA-DQ6-derived peptide recognized by mouse MHC class I H-2Db-restricted CD8+ T cells in HLA-DQ6 transgenic mice.
    Takeshita T; Fukui Y; Yamamoto K; Yamane K; Inamitsu T; Kamikawaji N; Sasazuki T
    Jpn J Hum Genet; 1997 Mar; 42(1):225-32. PubMed ID: 9184003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
    Scheibenbogen C; Lee KH; Mayer S; Stevanovic S; Moebius U; Herr W; Rammensee HG; Keilholz U
    Clin Cancer Res; 1997 Feb; 3(2):221-6. PubMed ID: 9815676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sHLA-I contaminating molecules as novel mechanism of ex vivo/in vitro transcriptional and posttranscriptional modulation of transforming growth factor-beta in CD8+ T lymphocytes and neutrophils after intravenous immunoglobulin treatment.
    Ghio M; Contini P; Negrini S; Proietti M; Gonella R; Ubezio G; Ottonello L; Indiveri F
    Transfusion; 2010 Mar; 50(3):547-55. PubMed ID: 19906035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of blood transfusions: the synergic role of soluble HLA Class I free heavy-chain molecules detectable in blood components.
    Ghio M; Contini P; Ubezio G; Mazzei C; Puppo F; Indiveri F
    Transfusion; 2008 Aug; 48(8):1591-7. PubMed ID: 18466172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
    Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
    Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.